No Data
Novartis Sells Agricultural Biologicals Assets to Syngenta
Novartis (NVS.US) BTK inhibitor "Rimebufin" has been the first to apply for market approval in China.
On February 27, the CDE official website showed that Novartis (NVS.US) BTK inhibitor remibrutinib tablets were the first to be submitted for listing in China.
Court Dismisses Novartis Challenge To Medicare Drug Price Negotiation Program
CDC A(H5N1) Bird Flu Response Update February 26, 2025; Confirmed 3 Human Cases Of H5 Bird Flu In People Who Became Ill In 2025 - Website
European stock markets reached record highs, with the market focusing on corporate Earnings Reports and the Ukraine issue.
European stock markets have risen to record highs, bolstered by a series of corporate Earnings Reports that have boosted market confidence, while investors are focused on negotiations surrounding a peace agreement for Ukraine. The Stoxx 600 Index closed up 1%, breaking through the record high reached last week. Anheuser-Busch Inbev rose 8.6% after reporting better-than-expected profits, with increased marketing efforts driving sales of its largest brand, and signs of recovery also appearing in the key USA market. Construction stocks and Insurance outperformed the Large Cap, while media stocks saw the largest declines. Santander rose 3.1%, stating that after achieving record profits in 2024, it would increase dividends by nearly 20%. On the other hand, Novartis fell 3.
Novartis Stockholder Sandoz to Reportedly Sell 26.5 Million Shares
